Casdin Capital Overview

  • Investor Type
  • Hedge Fund

  • Status
  • Active

  • Professionals
  • 6

Professionals
  • Investments
  • 234

  • Portfolio
  • 110

  • Exits
  • 71

Exits

Casdin Capital General Information

Description

Founded in 2012, Casdin Capital is a hedge fund manager based in New York, New York. The firm seeks to make venture capital investments in companies operating in the biotechnology, healthcare, life science, information technology, and industrial sectors across the United States. The firm primarily focuses on small and medium-sized market equity investments.

Contact Information

Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
  • 1350 Avenue of the Americas
  • Suite 2600
  • New York, NY 10019
  • United States
+1 (212) 000-0000

Casdin Capital Investments (234)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
iVexSol 26-Jan-2023 Later Stage VC 000.00 Discovery Tools (Healthcare) Generating Revenue
0000 00000000 10-Jan-2023 0000 00000 00.00 Other Healthcare Technology Systems Generating Revenue
000000 05-Jan-2023 00000 00000 00000 Other Healthcare Technology Systems Generating Revenue
000000 000000 08-Dec-2022 00000 00000 00.00 Other Commercial Products Stealth
000000000 17-Nov-2022 00000 00000 00000 Drug Discovery Generating Revenue
0000 000 10-Oct-2022 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 00000 000000000 00.0
000000000 00000000 21-Sep-2022 00000 00000 000.00 Biotechnology Generating Revenue
00000000000000 08-Sep-2022 00000 00000 0000 Other Healthcare Services Generating Revenue 000 000000
Meiogenix 18-Aug-2022 Later Stage VC 000.00 Biotechnology Generating Revenue/Not Profitable
Structure Therapeutics 01-Aug-2022 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 234 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Casdin Capital Exits (71)

Company Name Exit Date Exit Type Exit Size
Prime Medicine 20-Oct-2022 IPO 00000
0000000000 31-Aug-2022 000000000000000000 000.00
00000 21-Jul-2022 000 0000
00000000 14-Jul-2022 0000000000: 000000
00000000 000000000 16-Jun-2022 000000000 00000000
000000 00000000000 08-Feb-2022 000000000000000000 00.000
000000 30-Dec-2021 000000 0000000000 0000
000000000 000000 10-Dec-2021 000 000.00
LianBio 01-Nov-2021 IPO 00000
Exscientia 01-Oct-2021 IPO 00000
You’re viewing 10 of 71 exits. Get the full list »

Casdin Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Casdin Capital Team (21)

Name Title Deals Funds Boards Office
Lawrence Canzoneri Chief Financial Officer New York, NY
Alexandria Fisk Chief Operating Officer New York, NY
Angelo Crupi Chief Compliance Officer New York, NY
Eli Casdin Founder & Chief Investment Officer 00 0 00 New York, NY
Randy White Director, Business Development New York, NY
You’re viewing 5 of 21 team members. Get the full list »

Casdin Capital Co-Investors (585)

Name With Exits Lead Partner Series Industry
GV 24 0 Series chart Industry bar
Alexandria Venture Investments 00 0 0 Series chart Industry bar
Perceptive Advisors 00 0 0 Series chart Industry bar
Nextech Invest 00 0 0 Series chart Industry bar
The Invus Group 00 0 0 Series chart Industry bar
You’re viewing 5 of 585 co-investors. Get the full list »